Literature DB >> 10734228

Biophysical characterization of interactions between the core binding factor alpha and beta subunits and DNA.

Y Y Tang1, B E Crute, J J Kelley, X Huang, J Yan, J Shi, K L Hartman, T M Laue, N A Speck, J H Bushweller.   

Abstract

Core binding factors (CBFs) play key roles in several developmental pathways and in human disease. CBFs consist of a DNA binding CBFalpha subunit and a non-DNA binding CBFbeta subunit that increases the affinity of CBFalpha for DNA. We performed sedimentation equilibrium analyses to unequivocally establish the stoichiometry of the CBFalpha:beta:DNA complex. Dissociation constants for all four equilibria involving the CBFalpha Runt domain, CBFbeta, and DNA were defined. Conformational changes associated with interactions between CBFalpha, CBFbeta, and DNA were monitored by nuclear magnetic resonance and circular dichroism spectroscopy. The data suggest that CBFbeta 'locks in' a high affinity DNA binding conformation of the CBFalpha Runt domain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10734228     DOI: 10.1016/s0014-5793(00)01312-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  17 in total

Review 1.  RUNX1-dependent mechanisms in biological control and dysregulation in cancer.

Authors:  Deli Hong; Andrew J Fritz; Jonathan A Gordon; Coralee E Tye; Joseph R Boyd; Kirsten M Tracy; Seth E Frietze; Frances E Carr; Jeffrey A Nickerson; Andre J Van Wijnen; Anthony N Imbalzano; Sayyed K Zaidi; Jane B Lian; Janet L Stein; Gary S Stein
Journal:  J Cell Physiol       Date:  2018-12-04       Impact factor: 6.384

2.  HIV type 1 viral infectivity factor and the RUNX transcription factors interact with core binding factor β on genetically distinct surfaces.

Authors:  Judd F Hultquist; Rebecca M McDougle; Brett D Anderson; Reuben S Harris
Journal:  AIDS Res Hum Retroviruses       Date:  2012-08-13       Impact factor: 2.205

3.  Core-binding factor subunit beta is not required for non-primate lentiviral Vif-mediated APOBEC3 degradation.

Authors:  Youwei Ai; Dantong Zhu; Cuihui Wang; Chao Su; Jian Ma; Jianzhang Ma; Xiaojun Wang
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

4.  Runx1 dose-dependently regulates endochondral ossification during skeletal development and fracture healing.

Authors:  Do Y Soung; Laleh Talebian; Christina J Matheny; Rosa Guzzo; Maren E Speck; Jay R Lieberman; Nancy A Speck; Hicham Drissi
Journal:  J Bone Miner Res       Date:  2012-07       Impact factor: 6.741

5.  A mutation in the S-switch region of the Runt domain alters the dynamics of an allosteric network responsible for CBFbeta regulation.

Authors:  Zhe Li; Steven M Lukasik; Yizhou Liu; Jolanta Grembecka; Izabela Bielnicka; John H Bushweller; Nancy A Speck
Journal:  J Mol Biol       Date:  2006-10-04       Impact factor: 5.469

6.  Core-binding factor influences the disease specificity of Moloney murine leukemia virus.

Authors:  A F Lewis; T Stacy; W R Green; L Taddesse-Heath; J W Hartley; N A Speck
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

7.  CBFbeta is critical for AML1-ETO and TEL-AML1 activity.

Authors:  Liya Roudaia; Matthew D Cheney; Ekaterina Manuylova; Wei Chen; Michelle Morrow; Sangho Park; Chung-Tsai Lee; Prabhjot Kaur; Owen Williams; John H Bushweller; Nancy A Speck
Journal:  Blood       Date:  2009-01-29       Impact factor: 22.113

8.  PI2PE: A Suite of Web Servers for Predictions Ranging From Protein Structure to Binding Kinetics.

Authors:  Sanbo Qin; Huan-Xiang Zhou
Journal:  Biophys Rev       Date:  2012-07-25

9.  Distinct contributions of conserved modules to Runt transcription factor activity.

Authors:  Pegine B Walrad; Saiyu Hang; Genevieve S Joseph; Julia Salas; J Peter Gergen
Journal:  Mol Biol Cell       Date:  2010-05-12       Impact factor: 4.138

10.  Commitment to the osteoblast lineage is not required for RANKL gene expression.

Authors:  Carlo Galli; Qiang Fu; Wenfang Wang; Bjorn R Olsen; Stavros C Manolagas; Robert L Jilka; Charles A O'Brien
Journal:  J Biol Chem       Date:  2009-03-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.